Sure, I meant for the non-technical aspects that the previous poster mentioned - chain of custody, sample integrity.
A clinical lab that is used to running these kinds of (very common) protocols will see no difference in this protocol from others they commonly run (from a chain of custody, sample integrity, etc. perspective), just with a slight change to their reagents to specifically test for COVID. Their handling should be no different.